Gyre Therapeutics, Inc.
US
Gyre Therapeutics, Inc.: 3 links from the documents of the companies and the register.
Customers 3
| Entity | Figure | Evidence | Documents |
|---|---|---|---|
| Sinopharm Group Company Limited | 51.7% of the revenue of the supplier, fiscal year ended 31 Dec 2025 | Stated | Form 10-K for the fiscal year ended 31 December 2025 |
| China Resources Pharmaceutical Group Limited | 13.3% of the revenue of the supplier, fiscal year ended 31 Dec 2025 | Stated | Form 10-K for the fiscal year ended 31 December 2025 |
| Shanghai Pharmaceuticals Holding Company Limited | 11.6% of the revenue of the supplier, fiscal year ended 31 Dec 2025 | Stated | Form 10-K for the fiscal year ended 31 December 2025 |
Each link names the documents that state it, with the class of its evidence: stated by one party, confirmed by both, or stated by the register of legal entities. A commitment is the commitment at the date of the agreement.